...ailable to them to reference if they were ever unsure. The second goal was also met. She stated two of the risk factors that she could face contracting a virus and that she will take the needed precautions to avoid death. Lastly the patient confided in me and discussed her feeling identifying three of her emotions and asked for more information on the support groups she could join. Regina also wrote down the websites I referred to her and I gave her a pamphlet on coping with leukemia. Even though she has already learned a lot about her diagnosis there is always more to be taught.
For the majority of Americans, treatment for diagnosis is a huge financial burden. The probability of incurring a cancer diagnosis is a petrifying situation for most people. A cancer diagnosis in the United States entails a myriad of complications for a person as it is often unyielding, unwelcomed, and unexpected. In a free market economy such as the United States, commodities purchased by preference can a have wide price range based upon on what society deems is the reasonable value of the commodity. Cancer drugs prices in the United States are notorious for their expensive cost. Patented cancer medications in the United States have seen a 5 to 10 fold increase in pricing from early 2000 to contemporary (Kantarjian,
The rise in cost of prescription drugs affects all sectors of the health care industry, including private insurers, public programs, and patients. Spending on prescription drugs continues to be an important health care concern, particularly in light of rising pharmaceutical costs and the aging population. Prescription drugs have grown to become an essential component of health care. For millions of Americans, prescription drugs are necessary to their health and ability to function in society. While prescriptions are a relatively small portion of overall health spending, they are a main reason for certain health spending trends, growing almost twice as fast all other health services in recent years. Prescription costs can be the costliest expense in your budget, especially if you are on a fixed income. The wealthy can easily afford their medications, but for an increasing population such as the elderly, choosing among purchasing medication, paying bills, or buying food is a real concern.
During the winter of my sophomore year of high school my aunt, whom I am very close with, was diagnosed with stage three ovarian and cervical cancer. She underwent various surgeries and chemotherapy treatments, spent weeks in the hospital, and many more weeks battling the effects of the chemotherapy from home.
The implications for us a APNs is that some patients might not be able to afford their medications, and we should be aware of that when prescribing, either we can prescribe a generic, or cheaper option of a medication, or we can research about other option like subsidies, or grants, etc. and facilitate their way to access those.
...erefore a justification for a higher prices for treatments because of the reduce cost of complications. Though the risk and cost will be focus on a smaller patient population which takes an effect on the volume sold. Biological-based drugs have longer periods of exclusivity, so the pharmaceutical companies can take advantage of the revenue of the drug and recoup the costs of R&D. Therefore, change in focus of treatment to large-molecule drugs is a more appealing option than a partnership.
Around 60% percent of Americans depend on prescription drugs to treat acute and chronic illnesses these range from diabetes, heart diseases, arthritis, high blood pressure and depression (Campanelli, 2012). These drugs play a vital role in the well-being of Americans. These drugs are associated for increasing the lifespan of Americans from 47 years to 78 years. The elderly in our nation, people who are 65 years and above, majority of them in a month take prescription drugs once or more times (Kaufman, et al, 2002). The prices of prescription drugs have risen at an alarming rate in the past few years this has threatened the access and affordability of these drugs. Every day in the papers and news channels, we hear how the costs
Moreover, some of the new drugs being introduced at such large prices have only slight marginal improvements over the already pre-existing drugs. One example of this would be Zaltrap, a drug approved to treat colorectal cancer. Zaltrap was discovered by Regeneron, an emerging biopharmaceutical company, but sold by the French drug maker Sanofi. Yet it worked no better in clinical trials than Roche’s cancer drug called Avastin, which on average adds only 1.4 months to life expectancy for patients inflicted with advanced colorectal cancer. Sanofi priced Zaltrap at $11,000 a month, which is twice Avastin’s price. At any rate, there was resistance. Doctors at Memorial Sloan-Kettering in New York, which is one of the world’s leading cancer centers,
This essay will critically discuss about systemic anti cancer therapy induce nausea and vomiting, specifically patient receiving chemotherapy like Paclitaxel commonly given to our patients in the research unit. This one of the common side effect that patients can encounter while having chemothera-py treatment, it can have a notable impact on patient’s quality of life and af-fect daily activities. (Cohen, de Moor, Eisenberg, Ming, and Hu, 2007). It can also significantly affect cancer treatment and its patient’s compliance. This side effect is classified in three categories, acute, delayed and anticipatory. Acute nausea and vomiting can be experienced by the patient within 24 hours after receiving chemotherapy treatment. On the other
The Relay for Life fundraisers, Saint Jude's Research Hospital ads, and pink ribbons on the backs of cars: just a few of the many reminders of a tragedy that plagues this world. This seemed superfluous. My generation has grown up with mementos of cancer everywhere we look, and I did not understand why. Participating in The Relay for Life was just another event for me; I never thought I would have an impact on cancer research. Eventually I stopped participating in it because it seemed to do nothing. I walked for years, but there was no cure for cancer. I had given up.